MTMT-ben szereplő publikációk tallózása szerző szerint "SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika"

A találatok rendezése: Rendezés: Találatok:

  • Veres, Gábor; Szabó, Dolóresz; Herczegné Várkonyi, Ágnes; Tari B; Polgar M; B Kovacs J; Horvath A; Tomsits, Erika; Tokodi I; Bodánszky, Hedvig; Dezsőfi, Antal; Szakos E; Vass, Noémi; Ruszinko V; Kovács, Márta; Müller, Katalin Eszter; Arató, András (2010)
    Infliximab, the chimeric antibody to tumor necrosis factor-alpha, is indicated for medically refractory pediatric Crohn disease. Aim of our study was to examine the efficacy and side effects of infliximab therapy in Hungarian ...
  • Szász, A Marcell; Lánczky A; Nagy, Ádám; Förster S; Hark K; Green JE; Boussioutas A; Busuttil R; Szabó, András; Győrffy, Balázs (2016)
    INTRODUCTION: Multiple gene expression based prognostic biomarkers have been repeatedly identified in gastric carcinoma. However, without confirmation in an independent validation study, their clinical utility is limited. ...
  • Pongor, Lőrinc; Munkácsy, Gyöngyi; Vereczkey, I; Pete, Imre; Győrffy, Balázs (2020)
    Tumor heterogeneity is a consequence of clonal evolution, resulting in a fractal-like architecture with spatially separated main clones, sub-clones and single-cells. As sequencing an entire tumor is not feasible, we ask ...
  • Shih, DJ; Northcott, PA; Remke, M; Korshunov, A; Ramaswamy, V; Kool, M; Luu, B; Yao, Y; Wang, X; Dubuc, AM; Garzia, L; Peacock, J; Mack, SC; Wu, X; Rolider, A; Morrissy, AS; Cavalli, FM; Jones, DT; Zitterbart, K; Faria, CC; Schuller, U; Kren, L; Kumabe, T; Tominaga, T; Shin, Ra Y; Garami, Miklós; Hauser, Péter; Chan, JA; Robinson, S; Bognár, László; Klekner, Álmos; Saad, AG; Liau, LM; Albrecht, S; Fontebasso, A; Cinalli, G; De Antonellis, P; Zollo, M; Cooper, MK; Thompson, RC; Bailey, S; Lindsey, JC; Di Rocco, C; Massimi, L; Michiels, EM; Scherer, SW; Phillips, JJ; Gupta, N; Fan, X; Muraszko, KM; Vibhakar, R; Eberhart, CG; Fouladi, M; Lach, B; Jung, S; Wechsler-Reya, RJ; Fevre-Montange, M; Jouvet, A; Jabado, N; Pollack, IF; Weiss, WA; Lee, JY; Cho, BK; Kim, SK; Wang, KC; Leonard, JR; Rubin, JB; de Torres, C; Lavarino, C; Mora, J; Cho, YJD; Tabori, U; Olson, JM; Gajjar, A; Packer, RJ; Rutkowski, S; Pomeroy, SL; French, PJ; Kloosterhof, NK; Kros, JM; Van, Meir EG; Clifford, SC; Bourdeaut, F; Delattre, O; Doz, FF; Hawkins, CE; Malkin, D; Grajkowska, WA; Perek-Polnik, M; Bouffet, E; Rutka, JT; Pfister, SM; Taylor, M (2014)
    PURPOSE: Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group 3, and Group 4. Current medulloblastoma protocols stratify patients based on clinical features: patient age, metastatic stage, extent ...
  • Santarpia L; Bottai G; Kelly CM; Győrffy, Balázs; Székely, Borbála; Pusztai L (2016)
    : Advances in DNA and RNA sequencing revealed substantially greater genomic complexity in breast cancer than simple models of a few driver mutations would suggest. Only very few, recurrent mutations or copy-number variations ...
  • Pállinger, Éva; Horváth, Zsuzsanna; Csóka, Monika; Kovács, Gábor; Csaba, György (2011)
    Histamine, serotonin and triiodothyronine (T3) content of different circulating lymphocyte subsets of leukemic (acute lymphocytic leukemia, ALL) and non-leukemic (control) children were investigated by multicolor flow ...
  • Vannay Ádám; Fekete Andrea; Langer Róbert; Tóth Tibor; Sziksz Erna; Vásárhelyi Barna; Szabó Attila J.; Losonczy, György; Ádori Csaba; Gál Anikó; Tulassay Tivadar; Szabó András (2009)
    Background: Beneficial effects of dehydroepiandrosterone (DHEA) pretreatment were reported in ischaemia/reperfusion (I/R)-induced kidney damage. Methods: To investigate the mechanism of DHEA pretreatment during renal I/R ...
  • McCann LJ; Pilkington CA; Huber AM; Ravelli A; Appelbe D; Kirkham JJ; Williamson PR; Aggarwal A; Christopher-Stine L; Constantin, Tamás; Feldman BM; Lundberg I; Maillard S; Mathiesen P; Murphy R; Pachman LM; Reed AM; Rider LG; van Royen-Kerkof A; Russo R; Spinty S; Wedderburn LR; Beresford MW (2018)
    Objectives This study aimed to develop consensus on an internationally agreed dataset for juvenile dermatomyositis (JDM), designed for clinical use, to enhance collaborative research and allow integration of data between ...
  • Constantin, Tamás; Foeldvari, I; Pain, CE; Palinkas, A; Hoger, P; Moll, M; Nemkova, D; Weibel, L; Laczkovszki, M; Clements, P; Torok, KS (2018)
    Juvenile localized scleroderma (jLS), also known as morphea, is an orphan disease. Pediatric guidelines regarding diagnosis, assessment, and management are lacking. Our objective was to develop minimum standards of care ...
  • van Zanten SE; Baugh J; Chaney B; De Jongh D; Aliaga ES; Barkhof F; Noltes J; De Wolf R; Van Dijk J; Cannarozzo A; Damen-Korbijn CM; Lieverst JA; Colditz N; Hoffmann M; Warmuth-Metz M; Bison B; Jones DT; Sturm D; Gielen GH; Jones C; Hulleman E; Calmon R; Castel D; Varlet P; Giraud G; Slavc I; Van Gool S; Jacobs S; Jadrijevic-Cvrlje F; Sumerauer D; Nysom K; Pentikainen V; Kivivuori SM; Leblond P; Entz-Werle N; von Bueren AO; Kattamis A; Hargrave DR; Hauser P; Garami, Miklós; Thorarinsdottir HK; Pears J; Gandola L; Rutkauskiene G; Janssens GO; Torsvik IK; Perek-Polnik M; Gil-da-Costa MJ; Zheludkova O; Shats L; Deak L; Kitanovski L; Cruz O; La Madrid AM; Holm S; Gerber N; Kebudi R; Grundy R; Lopez-Aguilar E; Zapata-Tarres M; Emmerik J; Hayden T; Bailey S; Biassoni V; Massimino M; Grill J; Vandertop WP; Kaspers GJ; Fouladi M; Kramm CM; van Vuurden DG; members of the SIOPE DIPG Network (2017)
    Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly childhood malignancy. After 40 years of mostly single-center, often non-randomized trials with variable patient inclusions, there has been no improvement in ...
  • Szegedi, István; Jakab, Zsuzsanna; Masát P; Kiss, Csongor; Hungarian Pediatric Hematology-Oncology Group (HPOG) (2013)
    Acute myeloid leukemias (AML) comprising approximately 15 % of pediatric leukemias account for 30 % of all leukemic deaths in children worldwide. The 5-year overall survival (OS) rate now reaches 60-65 % in Western Europe, ...
  • Kovács Márta; Müller Katalin Eszter; Arató András; Lakatos Péter László; Kovacs Judit B.; Herczegné Várkonyi Ágnes; Sólyom Enikő; Polgár Marianne; Nemes Éva; Guthy Ildikó; Tokodi István; Tóth Gergely; Horváth Ágnes; Tárnok András; Micskey Éva; Tomsits Erika; Csoszánszky Noémi; Vass Noémi; Bódi Piroska; Dezsőfi Antal; Gárdos László; Micskey Éva; Papp Mária; Szűcs Dániel; Cseh Áron; Molnár Kriszta; Szabó Doloresz; Veres Gábor; Hungarian IBD Registry Group (2012)
  • Nguyen VTM; Barozzi I; Faronato M; Lombardo Y; Steel JH; Patel N; Darbre P; Castellano L; Győrffy B; Woodley L; Meira A; Patten DK; Vircillo V; Periyasamy M; Ali S; Frige G; Minucci S; Coombes RC; Magnani L (2015)
    Endocrine therapies target the activation of the oestrogen receptor alpha (ERα) via distinct mechanisms, but it is not clear whether breast cancer cells can adapt to treatment using drug-specific mechanisms. Here we ...
  • Galló, Nóra; Horváth, Klára; Czuppon, Krisztina; Tomsits, Erika; Felegyhazi, E.; Kovács, Gábor (2021)
    Background & aims: Cancer is one of the leading causes of death for children; however, appropriate nutritional status can positively affect disease progression and outcome. The aim of this study was to present our ...
  • West, DC; Kocherginsky, M; Tonsing-Carter, EY; Dolcen, DN; Hosfield, DJ; Lastra, RR; Sinnwell, JP; Thompson, KJ; Bowie, KR; Harkless, RV; Skor, MN; Pierce, CF; Styke, SC; Kim, CR; de Wet, L; Greene, GL; Boughey, JC; Goetz, MP; Kalari, KR; Wang, LW; Fleming, GF; Győrffy, Balázs; Conzen, SD (2018)
    Purpose: Although high glucocorticoid receptor (GR) expression in early-stage estrogen receptor (ER)-negative breast cancer is associated with shortened relapse-free survival (RFS), how associated GR transcriptional activity ...
  • Grabner B; Schramek D; Mueller KM; Moll HP; Svinka J; Hoffmann T; Bauer E; Blaas L; Hruschka N; Zboray K; Stiedl P; Nivarthi H; Bogner E; Gruber W; Mohr T; Zwick RH; Kenner L; Poli V; Aberger F; Stoiber D; Egger G; Esterbauer H; Zuber J; Moriggl R; Eferl R; Győrffy, Balázs; Penninger JM; Popper H; Casanova E (2015)
  • Reusz, György; Bárczi, Adrienn; Dégi, Arianna; Cseprekál, Orsolya; Kis, Éva; Szabó, Ádám; Csóka, Monika; Rudas, Gábor; Végh, Anna; Temmar, Mohamed; Salvi, Paolo (2020)
  • Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami, Miklós; Hauser, Péter; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC (2013)
    Molecular subclassification is rapidly informing the clinical management of medulloblastoma. However, the disease remains associated with poor outcomes and therapy-associated late effects, and the majority of patients are ...
  • Haltrich, Irén; Müller, Judit; Szabo J; Kovács, Gábor; Koós, Rozália; Poros A; Dobos, Matild; Fekete, György (2003)
    Donor-cell–derived hematopoietic malignancy is a rare event after bone marrow transplantation. Most cases in the literature occurred within the first year. We present a rare case of a female patient who had a bone marrow ...